During the past decade, Rigshospitalet; Onkologisk Klinik conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 11 clinical trials were completed, i.e. on average, 45.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rigshospitalet; Onkologisk Klinik" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Foundation Medicine, Inc." with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Rigshospitalet; Onkologisk Klinik" are "Solid Tumors" (9 trials), "Breast Cancer" (5 trials), "Neoplasms" (3 trials), "Ovarian Cancer" (3 trials) and "Non-small Cell Lung Cancer (NSCLC)" (2 trials). Many other conditions were trialed in "Rigshospitalet; Onkologisk Klinik" in a lesser frequency.

Most popular intervention types in "Rigshospitalet; Onkologisk Klinik" are "Drug" (33 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (13 trials), "Bevacizumab" (6 trials), "Paclitaxel" (6 trials), "Pertuzumab" (6 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Rigshospitalet; Onkologisk Klinik" are 30 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Rigshospitalet; Onkologisk Klinik". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Rigshospitalet; Onkologisk Klinik, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Rigshospitalet; Onkologisk Klinik, 18 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".